Regeneron Pharmaceuticals yesterday said it will buy genetic testing company 23andMe out of bankruptcy for US$256 million, a ...

Stations are being redeveloped with a modern facade and updated structural design to enhance passenger appeal and visual identity.

Pfizer has joined the ranks of companies developing cancer drugs that target both PD-1 and VEGF – one of the hottest drug ...